APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Voriconazole

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchOral Voriconazole Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Voriconazole Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oral Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Voriconazole Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Voriconazole Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Oral Voriconazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Voriconazole include Zhuhai Rundu Pharmaceutical, Yangzijiang Pharmaceutical Group, Poly Pharm, Union-Bio science, Huahai Pharmaceutical, Brilliant Pharmaceuticals, Beijing Genetech Pharmaceutical, Viona Pharmaceuticals and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Oral Voriconazole market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Voriconazole and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Voriconazole revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oral Voriconazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Voriconazole Segment by Company

Zhuhai Rundu Pharmaceutical

Yangzijiang Pharmaceutical Group

Poly Pharm

Union-Bio science

Huahai Pharmaceutical

Brilliant Pharmaceuticals

Beijing Genetech Pharmaceutical

Viona Pharmaceuticals

Teva

Taj Pharmaceuticals

Sun Pharmaceutical

SiNi Pharma

Sandoz

Pfizer

Lupin Pharmaceuticals

Oral Voriconazole Segment by Type

Voriconazole Suspension

Voriconazole Capsules

Voriconazole Tablets

Oral Voriconazole Segment by Application

Hospital Pharmacy

Retail Pharmacy

Oral Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oral Voriconazole in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Voriconazole industry.

Chapter 3: Detailed analysis of Oral Voriconazole companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Voriconazolerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Voriconazole Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Voriconazole Suspension Table 3. Key Players of Voriconazole Capsules Table 4. Key Players of Voriconazole Tablets Table 4. Global Oral Voriconazole Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacy Table 6. Key Players of Retail Pharmacy Table 7. Global Oral Voriconazole Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Oral Voriconazole Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Oral Voriconazole Market Share by Region (2021-2026) Table 10. Global Oral Voriconazole Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Oral Voriconazole Market Share by Region (2027-2032) Table 12. Oral Voriconazole Industry Trends Table 13. Oral Voriconazole Industry Drivers Table 14. Oral Voriconazole Industry Opportunities and Challenges Table 15. Oral Voriconazole Industry Restraints Table 16. Global Oral Voriconazole Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Oral Voriconazole Revenue Market Share by Company (2021-2026) Table 18. Global Oral Voriconazole Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Oral Voriconazole Key Company Head Office and Area Served Table 20. Global Oral Voriconazole Company, Product Type & Application Table 21. Global Oral Voriconazole Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Oral Voriconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Oral Voriconazole Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Oral Voriconazole Revenue Market Share by Type (2021-2026) Table 28. Global Oral Voriconazole Revenue Market Share by Type (2027-2032) Table 29. Global Oral Voriconazole Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Oral Voriconazole Revenue Market Share by Application (2021-2026) Table 33. Global Oral Voriconazole Revenue Market Share by Application (2027-2032) Table 34. Zhuhai Rundu Pharmaceutical Company Information Table 35. Zhuhai Rundu Pharmaceutical Business Overview Table 36. Zhuhai Rundu Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product Portfolio Table 38. Zhuhai Rundu Pharmaceutical Recent Development Table 39. Yangzijiang Pharmaceutical Group Company Information Table 40. Yangzijiang Pharmaceutical Group Business Overview Table 41. Yangzijiang Pharmaceutical Group Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Yangzijiang Pharmaceutical Group Oral Voriconazole Product Portfolio Table 43. Yangzijiang Pharmaceutical Group Recent Development Table 44. Poly Pharm Company Information Table 45. Poly Pharm Business Overview Table 46. Poly Pharm Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Poly Pharm Oral Voriconazole Product Portfolio Table 48. Poly Pharm Recent Development Table 49. Union-Bio science Company Information Table 50. Union-Bio science Business Overview Table 51. Union-Bio science Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Union-Bio science Oral Voriconazole Product Portfolio Table 53. Union-Bio science Recent Development Table 54. Huahai Pharmaceutical Company Information Table 55. Huahai Pharmaceutical Business Overview Table 56. Huahai Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Huahai Pharmaceutical Oral Voriconazole Product Portfolio Table 58. Huahai Pharmaceutical Recent Development Table 59. Brilliant Pharmaceuticals Company Information Table 60. Brilliant Pharmaceuticals Business Overview Table 61. Brilliant Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Brilliant Pharmaceuticals Oral Voriconazole Product Portfolio Table 63. Brilliant Pharmaceuticals Recent Development Table 64. Beijing Genetech Pharmaceutical Company Information Table 65. Beijing Genetech Pharmaceutical Business Overview Table 66. Beijing Genetech Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Beijing Genetech Pharmaceutical Oral Voriconazole Product Portfolio Table 68. Beijing Genetech Pharmaceutical Recent Development Table 69. Viona Pharmaceuticals Company Information Table 70. Viona Pharmaceuticals Business Overview Table 71. Viona Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Viona Pharmaceuticals Oral Voriconazole Product Portfolio Table 73. Viona Pharmaceuticals Recent Development Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Teva Oral Voriconazole Product Portfolio Table 78. Teva Recent Development Table 79. Taj Pharmaceuticals Company Information Table 80. Taj Pharmaceuticals Business Overview Table 81. Taj Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Taj Pharmaceuticals Oral Voriconazole Product Portfolio Table 83. Taj Pharmaceuticals Recent Development Table 84. Sun Pharmaceutical Company Information Table 85. Sun Pharmaceutical Business Overview Table 86. Sun Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sun Pharmaceutical Oral Voriconazole Product Portfolio Table 88. Sun Pharmaceutical Recent Development Table 89. SiNi Pharma Company Information Table 90. SiNi Pharma Business Overview Table 91. SiNi Pharma Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. SiNi Pharma Oral Voriconazole Product Portfolio Table 93. SiNi Pharma Recent Development Table 94. Sandoz Company Information Table 95. Sandoz Business Overview Table 96. Sandoz Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Sandoz Oral Voriconazole Product Portfolio Table 98. Sandoz Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Pfizer Oral Voriconazole Product Portfolio Table 103. Pfizer Recent Development Table 104. Lupin Pharmaceuticals Company Information Table 105. Lupin Pharmaceuticals Business Overview Table 106. Lupin Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Lupin Pharmaceuticals Oral Voriconazole Product Portfolio Table 108. Lupin Pharmaceuticals Recent Development Table 109. North America Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 110. North America Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 111. North America Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 112. North America Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 113. North America Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Oral Voriconazole Market Size by Country (2021-2026) Table 115. North America Oral Voriconazole Market Size by Country (2027-2032) Table 116. Europe Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 117. Europe Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 118. Europe Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 119. Europe Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 120. Europe Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Oral Voriconazole Market Size by Country (2021-2026) Table 122. Europe Oral Voriconazole Market Size by Country (2027-2032) Table 123. China Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 124. China Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 125. China Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 126. China Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 128. Asia Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 129. Asia Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 130. Asia Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Oral Voriconazole Market Size by Country (2021-2026) Table 133. Asia Oral Voriconazole Market Size by Country (2027-2032) Table 134. South America, Middle East & Africa Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Oral Voriconazole Market Size by Type (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Oral Voriconazole Market Size by Application (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. South America, Middle East & Africa Oral Voriconazole Market Size by Country (2021-2026) Table 140. South America, Middle East & Africa Oral Voriconazole Market Size by Country (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Oral Voriconazole Product Image Figure 2. Global Oral Voriconazole Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oral Voriconazole Market Share by Type: 2025 VS 2032 Figure 4. Voriconazole Suspension Image Figure 5. Voriconazole Capsules Image Figure 6. Voriconazole Tablets Image Figure 7. Global Oral Voriconazole Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Oral Voriconazole Market Share by Application: 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Global Oral Voriconazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 13. Global Oral Voriconazole Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Oral Voriconazole Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Oral Voriconazole Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Oral Voriconazole Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oral Voriconazole Revenue Market Share by Type (2021-2032) Figure 20. Global Oral Voriconazole Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oral Voriconazole Revenue Market Share by Application (2021-2032) Figure 22. North America Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 23. North America Oral Voriconazole Market Share by Type (2021-2032) Figure 24. North America Oral Voriconazole Market Share by Application (2021-2032) Figure 25. North America Oral Voriconazole Market Share by Country (2021-2032) Figure 26. United States Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 27. Canada Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 29. Europe Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 30. Europe Oral Voriconazole Market Share by Type (2021-2032) Figure 31. Europe Oral Voriconazole Market Share by Application (2021-2032) Figure 32. Europe Oral Voriconazole Market Share by Country (2021-2032) Figure 33. Germany Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 34. France Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 36. Italy Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 37. Russia Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 39. China Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 40. China Oral Voriconazole Market Share by Type (2021-2032) Figure 41. China Oral Voriconazole Market Share by Application (2021-2032) Figure 42. Asia Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 43. Asia Oral Voriconazole Market Share by Type (2021-2032) Figure 44. Asia Oral Voriconazole Market Share by Application (2021-2032) Figure 45. Asia Oral Voriconazole Market Share by Country (2021-2032) Figure 46. Japan Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 50. India Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 51. Australia Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Oral Voriconazole Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Oral Voriconazole Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Oral Voriconazole Market Share by Country (2021-2032) Figure 56. Brazil Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 61. UAE Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 63. Chile Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Voriconazole Suspension
  • Voriconazole Capsules
  • Voriconazole Tablets
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Zhuhai Rundu Pharmaceutical
  • Yangzijiang Pharmaceutical Group
  • Poly Pharm
  • Union-Bio science
  • Huahai Pharmaceutical
  • Brilliant Pharmaceuticals
  • Beijing Genetech Pharmaceutical
  • Viona Pharmaceuticals
  • Teva
  • Taj Pharmaceuticals
  • Sun Pharmaceutical
  • SiNi Pharma
  • Sandoz
  • Pfizer
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oral Voriconazole Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Voriconazole Suspension
  5. 1.2.3 Voriconazole Capsules
  6. 1.2.4 Voriconazole Tablets
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Oral Voriconazole Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Retail Pharmacy
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Oral Voriconazole Growth Trends by Region
  13. 1.5.1 Global Oral Voriconazole Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Oral Voriconazole Market Size by Region (2021-2026)
  15. 1.5.3 Oral Voriconazole Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Oral Voriconazole Market Dynamics
  1. 2.1 Oral Voriconazole Industry Trends
  2. 2.2 Oral Voriconazole Industry Drivers
  3. 2.3 Oral Voriconazole Industry Opportunities and Challenges
  4. 2.4 Oral Voriconazole Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oral Voriconazole Revenue by Company (2021-2026)
  2. 3.2 Global Oral Voriconazole Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oral Voriconazole Key Company Head office and Area Served
  4. 3.4 Global Oral Voriconazole Company, Product Type & Application
  5. 3.5 Global Oral Voriconazole Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oral Voriconazole Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oral Voriconazole Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oral Voriconazole Tier 1, Tier 2, and Tier 3
4 Oral Voriconazole Market by Type
  1. 4.1 Global Oral Voriconazole Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oral Voriconazole Market Size by Type (2021-2032)
  3. 4.3 Global Oral Voriconazole Market Size Share by Type (2021-2032)
5 Oral Voriconazole Market by Application
  1. 5.1 Global Oral Voriconazole Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Voriconazole Market Size by Application (2021-2032)
  3. 5.3 Global Oral Voriconazole Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Zhuhai Rundu Pharmaceutical
  2. 6.1.1 Zhuhai Rundu Pharmaceutical Company Information
  3. 6.1.2 Zhuhai Rundu Pharmaceutical Business Overview
  4. 6.1.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Zhuhai Rundu Pharmaceutical Oral Voriconazole Product Portfolio
  6. 6.1.5 Zhuhai Rundu Pharmaceutical Recent Developments
  7. 6.2 Yangzijiang Pharmaceutical Group
  8. 6.2.1 Yangzijiang Pharmaceutical Group Company Information
  9. 6.2.2 Yangzijiang Pharmaceutical Group Business Overview
  10. 6.2.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Yangzijiang Pharmaceutical Group Oral Voriconazole Product Portfolio
  12. 6.2.5 Yangzijiang Pharmaceutical Group Recent Developments
  13. 6.3 Poly Pharm
  14. 6.3.1 Poly Pharm Company Information
  15. 6.3.2 Poly Pharm Business Overview
  16. 6.3.3 Poly Pharm Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Poly Pharm Oral Voriconazole Product Portfolio
  18. 6.3.5 Poly Pharm Recent Developments
  19. 6.4 Union-Bio science
  20. 6.4.1 Union-Bio science Company Information
  21. 6.4.2 Union-Bio science Business Overview
  22. 6.4.3 Union-Bio science Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Union-Bio science Oral Voriconazole Product Portfolio
  24. 6.4.5 Union-Bio science Recent Developments
  25. 6.5 Huahai Pharmaceutical
  26. 6.5.1 Huahai Pharmaceutical Company Information
  27. 6.5.2 Huahai Pharmaceutical Business Overview
  28. 6.5.3 Huahai Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Huahai Pharmaceutical Oral Voriconazole Product Portfolio
  30. 6.5.5 Huahai Pharmaceutical Recent Developments
  31. 6.6 Brilliant Pharmaceuticals
  32. 6.6.1 Brilliant Pharmaceuticals Company Information
  33. 6.6.2 Brilliant Pharmaceuticals Business Overview
  34. 6.6.3 Brilliant Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Brilliant Pharmaceuticals Oral Voriconazole Product Portfolio
  36. 6.6.5 Brilliant Pharmaceuticals Recent Developments
  37. 6.7 Beijing Genetech Pharmaceutical
  38. 6.7.1 Beijing Genetech Pharmaceutical Company Information
  39. 6.7.2 Beijing Genetech Pharmaceutical Business Overview
  40. 6.7.3 Beijing Genetech Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Beijing Genetech Pharmaceutical Oral Voriconazole Product Portfolio
  42. 6.7.5 Beijing Genetech Pharmaceutical Recent Developments
  43. 6.8 Viona Pharmaceuticals
  44. 6.8.1 Viona Pharmaceuticals Company Information
  45. 6.8.2 Viona Pharmaceuticals Business Overview
  46. 6.8.3 Viona Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viona Pharmaceuticals Oral Voriconazole Product Portfolio
  48. 6.8.5 Viona Pharmaceuticals Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Oral Voriconazole Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Taj Pharmaceuticals
  56. 6.10.1 Taj Pharmaceuticals Company Information
  57. 6.10.2 Taj Pharmaceuticals Business Overview
  58. 6.10.3 Taj Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Taj Pharmaceuticals Oral Voriconazole Product Portfolio
  60. 6.10.5 Taj Pharmaceuticals Recent Developments
  61. 6.11 Sun Pharmaceutical
  62. 6.11.1 Sun Pharmaceutical Company Information
  63. 6.11.2 Sun Pharmaceutical Business Overview
  64. 6.11.3 Sun Pharmaceutical Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Oral Voriconazole Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Recent Developments
  67. 6.12 SiNi Pharma
  68. 6.12.1 SiNi Pharma Company Information
  69. 6.12.2 SiNi Pharma Business Overview
  70. 6.12.3 SiNi Pharma Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SiNi Pharma Oral Voriconazole Product Portfolio
  72. 6.12.5 SiNi Pharma Recent Developments
  73. 6.13 Sandoz
  74. 6.13.1 Sandoz Company Information
  75. 6.13.2 Sandoz Business Overview
  76. 6.13.3 Sandoz Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Sandoz Oral Voriconazole Product Portfolio
  78. 6.13.5 Sandoz Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Pfizer Oral Voriconazole Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Lupin Pharmaceuticals
  86. 6.15.1 Lupin Pharmaceuticals Company Information
  87. 6.15.2 Lupin Pharmaceuticals Business Overview
  88. 6.15.3 Lupin Pharmaceuticals Oral Voriconazole Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Lupin Pharmaceuticals Oral Voriconazole Product Portfolio
  90. 6.15.5 Lupin Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Oral Voriconazole Market Size (2021-2032)
  2. 7.2 North America Oral Voriconazole Market Size by Type
  3. 7.2.1 North America Oral Voriconazole Market Size by Type (2021-2026)
  4. 7.2.2 North America Oral Voriconazole Market Size by Type (2027-2032)
  5. 7.2.3 North America Oral Voriconazole Market Share by Type (2021-2032)
  6. 7.3 North America Oral Voriconazole Market Size by Application
  7. 7.3.1 North America Oral Voriconazole Market Size by Application (2021-2026)
  8. 7.3.2 North America Oral Voriconazole Market Size by Application (2027-2032)
  9. 7.3.3 North America Oral Voriconazole Market Share by Application (2021-2032)
  10. 7.4 North America Oral Voriconazole Market Size by Country
  11. 7.4.1 North America Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oral Voriconazole Market Size by Country (2021-2026)
  13. 7.4.3 North America Oral Voriconazole Market Size by Country (2027-2032)
  14. 7.4.4 North America Oral Voriconazole Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oral Voriconazole Market Size (2021-2032)
  2. 8.2 Europe Oral Voriconazole Market Size by Type
  3. 8.2.1 Europe Oral Voriconazole Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oral Voriconazole Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oral Voriconazole Market Share by Type (2021-2032)
  6. 8.3 Europe Oral Voriconazole Market Size by Application
  7. 8.3.1 Europe Oral Voriconazole Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oral Voriconazole Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oral Voriconazole Market Share by Application (2021-2032)
  10. 8.4 Europe Oral Voriconazole Market Size by Country
  11. 8.4.1 Europe Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oral Voriconazole Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oral Voriconazole Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oral Voriconazole Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oral Voriconazole Market Size (2021-2032)
  2. 9.2 China Oral Voriconazole Market Size by Type
  3. 9.2.1 China Oral Voriconazole Market Size by Type (2021-2026)
  4. 9.2.2 China Oral Voriconazole Market Size by Type (2027-2032)
  5. 9.2.3 China Oral Voriconazole Market Share by Type (2021-2032)
  6. 9.3 China Oral Voriconazole Market Size by Application
  7. 9.3.1 China Oral Voriconazole Market Size by Application (2021-2026)
  8. 9.3.2 China Oral Voriconazole Market Size by Application (2027-2032)
  9. 9.3.3 China Oral Voriconazole Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oral Voriconazole Market Size (2021-2032)
  2. 10.2 Asia Oral Voriconazole Market Size by Type
  3. 10.2.1 Asia Oral Voriconazole Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oral Voriconazole Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oral Voriconazole Market Share by Type (2021-2032)
  6. 10.3 Asia Oral Voriconazole Market Size by Application
  7. 10.3.1 Asia Oral Voriconazole Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oral Voriconazole Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oral Voriconazole Market Share by Application (2021-2032)
  10. 10.4 Asia Oral Voriconazole Market Size by Country
  11. 10.4.1 Asia Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oral Voriconazole Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oral Voriconazole Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oral Voriconazole Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oral Voriconazole Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oral Voriconazole Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oral Voriconazole Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oral Voriconazole Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oral Voriconazole Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oral Voriconazole Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oral Voriconazole Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oral Voriconazole Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oral Voriconazole Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oral Voriconazole Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oral Voriconazole Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oral Voriconazole Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oral Voriconazole Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oral Voriconazole Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst